Functional experiments found that 125I-Epo bound to Caki-2 human RCC cell line with intermediate affinity, and Epo induced the increase of cell number dose-dependently in Caki-2 and 786-0 human RCC cell lines and RAG murine RCC cell line [10]. This evidence concerns the gene EPO and renal cell carcinoma.